I agree with what you say except for your first su

I agree with what you say except for your first substantive paragraph. There was not a great waste of time with Leronlimab investor questions. FDA has a whole apparatus to deal with response to the public. The only time consuming comments are those coming out of Congress or elsewhere in the administration. Those replies do go to the Subject Matter Experts to help draft an answer. There was little out of the FDA on Leronlimab, so little time was spent on fashioning public replies. Some of the thin skinned bureaucrats saw the medical community beginning to question their findings. So they reacted like second graders and drafted a tantrum, unbalanced reply which you note. The only thing they are handcuffed by is their bureaucratic inertia. The declaration of a National Emergency can be used to get around existing procedures. But the FDA has not. I didn’t expect the FDA to issue a full authorization but they have extraordinary authority to find some inventive work around. The Philippines seems to have. Our mini-minds have not. The rest of what you say is eloquently put.